Allen Loyd V
International Journal of Pharmaceutical Compounding.
Int J Pharm Compd. 2020 Jul-Aug;24(4):305-309.
The effect of pH on solubility and stability is a critical factor in the formulation of parenteral dosage forms and becomes more complicated in intravenous admixtures since the additives and the vehicle may have different pH values. This is especially important as a significant number of parenteral medications require some compounding involving dissolution of lyophilized powders, dilution of drug doses for infusion, mixing of dextrose, amino acids, vitamins, and electrolytes for parenteral nutrition, etc. A change in the acid-base environment of a drug involves both the solubility and stability characteristics and can be critically related to pH as follows: (1) as a solution goes away from the pH of maximum solubility, the drug can precipitate out of solution, and (2) as the solution goes away from the pH of maximum stability, the drug can degrade more rapidly and have a short beyond-use date. This fifth of a series of articles on intravenous admixture preparation considerations represents an introduction on pH considerations, which is presented in two parts, pH basics and applications, covering pH Considerations - Basics (In part 5 of this series): Basics of pH, pKa and Dissociation Constants, pH and Solubility, pH and Stability; and pH Considerations - Applications (in part 6 of this series): Vehicle Characteristics, Selected Injectable Characteristics, IV Admixtures and Syringe Admixtures, and General Summary of pH Effects.
pH值对溶解度和稳定性的影响是注射剂剂型配方中的关键因素,在静脉混合液中更为复杂,因为添加剂和溶媒可能具有不同的pH值。这一点尤为重要,因为大量注射用药物需要进行一些配制工作,包括冻干粉末的溶解、输液药物剂量的稀释、用于肠外营养的葡萄糖、氨基酸、维生素和电解质的混合等。药物酸碱环境的变化涉及溶解度和稳定性特征,并且与pH值密切相关,具体如下:(1) 当溶液的pH值偏离最大溶解度的pH值时,药物可能会从溶液中析出;(2) 当溶液的pH值偏离最大稳定性的pH值时,药物可能会更快降解,有效期缩短。这是关于静脉混合液配制注意事项系列文章的第五篇,介绍了pH值相关注意事项,分两部分呈现,即pH值基础和应用,涵盖pH值注意事项 - 基础(本系列第5部分):pH值、pKa和离解常数的基础,pH值与溶解度,pH值与稳定性;以及pH值注意事项 - 应用(本系列第6部分):溶媒特性、特定注射剂特性、静脉混合液和注射器混合液,以及pH值影响的总体总结。